Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(3;3)(p22;p22) GLB1/CMTM7

Written2018-01Jean-Loup Huret, Philippe Dessen

(Note : for Links provided by Atlas : click)

Identity

Atlas_Id 107174
Phylum Female organs: Breast::
Note Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this gene, go to  How to contribute

Clinics and Pathology

Disease Female organs: Breast:Adenocarcinoma

Genes involved and Proteins

Gene NameGLB1

Gene NameCMTM7
Location 3p22.3

Bibliography

Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, Rye IH, Nyberg S, Wolf M, Borresen-Dale AL, Kallioniemi O
Genome Biol 2011;12(1):R6
PMID 21247443
 
A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines
Asmann YW, Hossain A, Necela BM, Middha S, Kalari KR, Sun Z, Chai HS, Williamson DW, Radisky D, Schroth GP, Kocher JP, Perez EA, Thompson EA
Nucleic Acids Res 2011 Aug;39(15):e100
PMID 21622959
 


Translocations implicated (Data extracted from papers in the Atlas)

 t(3;3)(p22;p22) GLB1/CMTM7

External links

Mitelman database t(3;3)(p22;p22) [CaseList]    t(3;3)(p22;p22) [Transloc - MCList] GLB1/CMTM7 [Fusion - MCList]
COSMIC[ GLB1 ]   [ CMTM7 ]
arrayMap arrayMap ((UZH-SIB Zurich)   [auto + random 100 samples .. if exist ]   [tabulated segments]
 
 
Disease databaset(3;3)(p22;p22) GLB1/CMTM7
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Feb 23 20:34:12 CET 2018


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.